DiamonEx Limited (ASX:DON) AIM
RELEASE
22 August 2008
PRIVATE PLACEMENT TO BOTSWANA INSTITUTIONS
The Company wishes to announce the placement of 18 million shares
with two major Botswana Institutions at the price of A$0.20 per share
raising in total A$3.6 million. The money will be used to strengthen
the Company's cash reserves.
For and on behalf of the Board
Paul Crawford
Company Secretary
For further information contact:
Dan O'Neill
Managing Director
Tel: +61 7 3720 8944
Mob: +61 407 596 942
Email: diamonex@diamonex.com.au
Mark Gray
Corporate Development
Tel: +61 7 3720 8944
Mob: +61 412 899 979
Email: diamonex@diamonex.com.au
Will Souter or Rob Adamson
RFC Corporate Finance Ltd (Nomad)
Tel: +61 2 9250 0050
+61 2 9250 0041
Email: will.souter@rfc.com.au
rob.adamson@rfc.com.au
Richard Hail
Fox-Davies Capital Ltd (AIM Broker)
Tel: +44 20 7936 5200
Email: Richard.Hail@fdcap.com
Jos Simson or Leesa Peters
Conduit PR - Investor Relations
Tel: +44 20 7429 6603
+44 78 9987 0450
Email: jos@conduitpr.com
About DiamonEx:
DiamonEx is an emerging diamond producer having developed a 330,000
carat per year diamond mine at Lerala, in eastern Botswana. The mine
is 100% owned and is located in an area that produces up to 30% of
the worlds diamonds by value. The company also owns 15,000 sq km of
mineral rights in Botswana which it is actively exploring for
diamonds, as well as a 9.3 hectare diamondiferous kimberlitic pipe in
northern Colorado, USA, which it is currently evaluating for grade
and value. DiamonEx is listed on the Australian Stock Exchange
(ASX), the Alternative Investment Market in London (AIM), and the
Botswana Stock Exchange (BSE).
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional
securities and agreement
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99,
1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.
Name of entity
DIAMONEX LIMITED
ABN
26 091 951 978
We (the entity) give ASX the following information:
Part 1 - All issue
1 Class of securities issued or Ordinary Shares
to be issued
2 Number of securities issued
or to be issued (if known) or 18,000,000
maximum number which may be
issued
3 Principal terms of the As per existing ordinary fully paid
securities shares.
4 Do the securities rank
equally in all respects from
the date of allotment with an Yes
existing class of quoted
securities?
5 Issue price or consideration $0.20
6 Purpose of the issue Strengthen company's cash reserves
7 Dates of entering securities
into uncertificated holdings 21 August 2008
or despatch of certificates.
Number Class
8 Number and class of all 173,424,196 Ordinary shares
securities quoted on ASX
Number Class
9 Number and class of all 2,000,000 Options exercisable at 35
securities not quoted on ASX cents on or before 29
1,000,433 December 2011
Options exercisable at 31
1,000,000 cents on or before 22
October 2010
422,850 Options exercisable at 30
cents on or before 1
November 2010
1,550,000 Options exercisable at
GBP0.16(A$0.37) on or
before 16 January 2011
Options exercisable at
A$0.37 on or before 17
April 2013
10 Dividend policy on the Not Applicable
increased capital (interests)
Part 2 - Bonus issue or pro rata issue
11 Is security holder approval required?
12 Is the issue renounceable or non-renounceable?
13 Ratio in which the securities will be offered
14 Class of securities to which the offer relates
15 Record date to determine entitlements
16 Will holdings on different registers (or subregisters) be
aggregated for calculating entitlements?
17 Policy for deciding entitlements in relation to fractions
18 Names of countries in which the entity has security holders who
will not be sent new issue documents
19 Closing date for receipt of acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting fee or commission
22 Names of any brokers to the issue
23 Fee or commission payable to the broker to the issue
24 Amount of any handling fee payable to brokers who lodge
acceptances or renunciations on behalf of security holders
25 If the issue is contingent on security holders' approval, the
date of the meeting
26 Date entitlement and acceptance form and prospectus or Product
Disclosure Statement will be sent to persons entitled
27 If the entity has issued options, and the terms entitle option
holders to participate on exercise, the date on which notices
will be sent to option holders
28 Date rights trading will begin (if applicable)
29 Date rights trading will end (if applicable)
30 How do security holders sell their entitlements in full through
a broker?
31 How do security holders sell part of their entitlements through
a broker and accept for the balance?
32 How do security holders dispose of their entitlements (except by
sale through a broker)?
33 Despatch date
Part 3 - Quotation of securities
34 Type of securities (tick one)
(a) X Securities described in Part 1
(b) All other securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
35 If the securities are equity securities, the names of the 20
largest holders of the additional securities, and the number and
percentage of additional securities held by those holders
36 If the securities are equity securities, a distribution schedule
of the additional securities setting out the number of holders
in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional securities
Entities that have ticked box 34(b)
38 Number of securities for which quotation is sought
39 Class of securities for which quotation is sought
40 Do the securities rank equally in all respects from
the date of allotment with an existing class of
quoted securities?
If not, please state:
* the date from which they do
* the extent to which they participate for the
next dividend, or interest payment
* the extent to which they do not rank
equally, other than in relation to the next
dividend, distribution or interest payment
41 Reason for request for quotation now
Number Class
42 Number and class of all securities quoted on ASX
(including the securities in clause 38)
Quotation agreement
1 Quotation of our additional securities is in ASX's absolute
discretion. ASX may quote the securities on any conditions it
decides.
2 We warrant the following to ASX.
* The issue of the securities to be quoted complies with the
law and is not for an illegal purpose.
* There is no reason why those securities should not be
granted quotation.
* An offer of the securities for sale within 12 months after
their issue will not require disclosure under section 707(3) or
section 1012C(6) of the Corporations Act.
* Section 724 or section 1016E of the Corporations Act does
not apply to any applications received by us in relation to any
securities to be quoted and that no-one has any right to return any
securities to be quoted under sections 737, 738 or 1016F of the
Corporations Act at the time that we request that the securities be
quoted.
* We warrant that if confirmation is required under section
1017F of the Corporations Act in relation to the securities to be
quoted, it has been provided at the time that we request that the
securities be quoted.
* If we are a trust, we warrant that no person has the right
to return the securities to be quoted under section 1019B of the
Corporations Act at the time that we request that the securities be
quoted.
3 We will indemnify ASX to the fullest extent permitted by law
in respect of any claim, action or expense arising from or connected
with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this
form. If any information or document not available now, will give it
to ASX before quotation of the securities begins. We acknowledge
that ASX is relying on the information and documents. We warrant
that they are (will be) true and complete.
Paul Crawford
Company Secretary
22 August 2008
---END OF MESSAGE---
DiamonEx Limited
http://www.diamonex.com.au/
ISIN: AU000000DON1
Stock Identifier: AIMX.DON
Related Companies
Social Media
Share this Article